Immunicum AB (publ) Interim Report January – March 2021

NEXT STORY
Change of Company Name
PREV STORY
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Press Release Oncology Venture is issuing 1,574,803 shares under its existing convertible loan note agreement with Negma Group LTD and Park Partners GP

author_avatar
NASDAQ Market News

The Global Endocrinology Drugs Market is expected to grow by USD 24.78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period

author_avatar
NASDAQ Market News

Global Immunoassay Market Will Reach USD 29.79 Billion By 2025: Zion Market Research

author_avatar
NASDAQ Market News